CGTN: China Makes Proposals for UN's Role in Post-Pandemic Era
22.9.2020 09:48:00 EEST | Business Wire | Press release
The United Nations, beginning with 51 signatories at the end of World War II, has now grown to be a 193-nation body. As it celebrates its 75th founding anniversary, the organization and multilateralism it represents are facing unprecedented challenges with the rise of unilateralism and protectionism.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200921005948/en/
The challenges are being compounded by COVID-19, which has infected more than 31 million people and taken over 960,000 lives worldwide.
"What kind of UN does the world need and what role should it play in the post-pandemic era?"
Chinese President Xi Jinping raised the question and made proposals on Monday when addressing the high-level meeting to commemorate the 75th anniversary of the UN via video link.
The UN should uphold justice as countries, regardless of their sizes, are equal and should respect each other, Xi said, noting that this is a requirement of the progress of the times and the most important principle in the UN Charter.
The organization should be committed to achieving shared growth through consultation and collaboration, he stressed, calling on countries around the world to maintain common security and share the fruits of development.
Xi called for increased representation and a louder voice for developing countries in the UN and upholding the purposes and principles of the UN Charter.
He said the UN should promote international cooperation and lead efforts to solve various problems in the world. It should advance security, development and human rights in a balanced manner and give more emphasis to development on its global agenda, he added.
Uphold multilateralism, enhance cooperation
"During the 75 years of the UN, the world has seen rapid progress of the human society, profound changes in international situations and fast development of multilateralism," the Chinese president said.
He reiterated China's commitment to multilateralism and determination to safeguard the international system with the UN at its core.
As the international community strives to find solutions to problems faced by mankind, "multilateralism" has been a buzzword during the 75th session of the UN General Assembly that opened last week.
UN Secretary-General Antonio Guterres urged world leaders to work together at a time when there is a surplus of multilateral challenges and a deficit of solutions. "The future we want, the United Nations we need, is reaffirming our collective commitment to multilateralism is under way," he said.
Indeed, the need for more – and more effective – multilateralism is well known, he said, stressing that national sovereignty – a pillar of the Charter of the United Nations – goes hand‑in‑hand with enhanced international cooperation, based on common values and shared responsibilities for progress.
Russian Foreign Minister Sergei Lavrov said the international community is becoming increasingly fragmented, adding that "this is largely attributable to the fact that some countries are meddling in the domestic affairs of other states and imposing unilateral sanctions."
"The world is tired of dividing lines, of separating states into friends and foes, and demands stepping up all-encompassing and inclusive mutual assistance and cooperation," he said.
German Chancellor Angela Merkel said the interests of individual member states had "too often" forced the UN to lag behind its ideals.
"Those who believe that they can get along better alone are mistaken. Our well-being is something that we share – our suffering too. We are one world," she told the General Assembly.
While customs and cultures may differ, cooperation requires unstinting efforts to overcome misunderstanding, and beyond that, to embrace respect, European Council President Charles Michel noted.
"It is not our rhetoric that will matter," he said, but rather, the collective actions taken to foster a better world.
The theme of this year's UN high-level sessions is "The Future We Want, the UN We Need: Reaffirming Our Collective Commitment to Multilateralism." It echoes Xi's consistent call to build a community with a shared future for mankind.
Meanwhile, 48 former UN and government officials from around the world released an open letter – "A Time for Renewal: Calling for a Strengthened Multilateral System" – last Friday, expressing their hope that the UN would be transformed into a "stronger, more accountable, inclusive multilateral system."
"There is an urgent need for an explicit recognition by global leaders that we are at a turning point and must act decisively to defend and rejuvenate multilateralism," they said, stressing that recovery from the COVID-19 pandemic needs national leadership and effective global cooperation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005948/en/
Contact information
Media:
Jiang Simin
jiang.simin@cgtn.com
+86 18826553286
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Venture Global Announces Closing of $1.5 Billion Senior Secured Vessel Financing Facility26.6.2026 23:30:00 EEST | Press release
Venture Global, Inc. (NYSE: VG) announced today that its wholly-owned subsidiary, Venture Global Shipping Holdings, LLC (“VGSH”), has entered into a Credit and Guaranty Agreement providing for a senior secured term loan facility (the “Facility”) in an aggregate principal amount of up to $1,500,000,000. The Facility will mature on June 26, 2032. Deutsche Bank and ING acted as coordinating lead arrangers for the Facility. ING also serves as facility agent and security trustee. VGSH intends to use the net proceeds from the Facility for general corporate purposes, including to reimburse Venture Global LNG, Inc. for payments previously made by it or its affiliates in connection with the acquisition of nine LNG carriers, funding certain reserve accounts, and paying transaction fees and expenses. About Venture Global Venture Global is an American producer and exporter of low-cost U.S. liquefied natural gas (“LNG”) with over 100 MTPA of capacity in production, construction, or development. Ven
Capco Recognized by OpenAI for Innovation and Responsible AI Leadership26.6.2026 21:00:00 EEST | Press release
Global management and technology consultancy Capco, a Wipro company,has been recognized by OpenAI for both AI innovation and responsible AI leadership. Capco received the AI Governance & Risk Excellence Award at the recent OpenAI Partner Summit 2026 in San Francisco, highlighting Capco’s ability to deliver enterprise-grade AI outcomes in highly regulated environments. The award recognizes Capco’s expert advantage when helping financial services and energy organizations to scale AI with confidence, balancing innovation with strong governance to reduce risk, strengthen compliance and improve customer outcomes. This award follows Capco winning the OpenAI Codex Hackathon, where its UK AI Lab competed against more than 30 teams and over 100 participants from across the OpenAI partner ecosystem. Capco's winning entry Sentra – a consulting-led, AI-powered retail banking solution – uses digital twin technology to identify vulnerable customers and recommend explainable next-best actions for fro
Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release
Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o
Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a
DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
